title: Respiratory compromise in patients with rattlesnake envenomation.
abstract: Respiratory compromise after rattlesnake envenomation (RSE) is an uncommon yet potentially lethal complication. We were interested in determining the frequency of respiratory compromise in patients treated for RSE. The incidence and indications for intubation were also determined. A retrospective chart review was conducted of all patients treated by medical toxicologists at a tertiary referral hospital between July, 1994 and November, 2000. Out of 294 total patients, 289 charts were reviewed. Of all 289 patients, 214 (74%) received Crotalidae Polyvalent Antivenin (Wyeth-Ayerst) and 23 (8%) had clinical evidence of respiratory compromise. Thirteen of 289 patients (4.4%) were intubated following RSE. No one was intubated for antivenin-induced complications. There were no deaths among studied patients during acute hospitalization. Respiratory compromise following RSE is rare, occurring in only 8% of studied patients. Only 2 patients (0.7%) required intubation as a direct consequence of RSE. No one required intubation for antivenin-induced hypersensitivity reactions.
authors.affiliation: Department of Medical Toxicology, Good Samaritan Regional Medical Center, Phoenix, Arizona 85006, USA.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Brooks
authors.forename: Kimberlie A
authors.initials: KA
authors.lastname: Graeme
authors.forename: Anne Michelle
authors.initials: AM
authors.lastname: Ruha
authors.forename: David A
authors.initials: DA
authors.lastname: Tanen
mesh_terms: D000818:Animals; D000997:Antivenins / Q000008:administration & dosage*; D001130:Arizona / Q000453:epidemiology; D016535:Bronchial Hyperreactivity / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D017839:Crotalus; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008297:Male; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000453:epidemiology* / Q000209:etiology* / Q000628:therapy; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D012909:Snake Bites / Q000150:complications* / Q000628:therapy*
chemical_list: D000997:Antivenins